London: Deloitte this week launched the Deloitte UK Centre for Health Solutions — a new research hub for the healthcare and life sciences industry, led by Karen Taylor OBE, the former Director of Health Value for Money at the National Audit Office.
- New healthcare and life sciences research hub to encourage and support innovation in healthcare;
- Karen Taylor OBE appointed to lead Deloitte Centre for Health Solutions.
Deloitte says the Centre will provide insights for the firm's healthcare and life sciences clients. It will actively promote an environment that encourages and supports innovation in health solutions, driving independent and objective research analysis into the most complex industry issues; creating and publishing evidence-based insights and points of view.
Simon Hammett, UK and EMEA healthcare and life sciences leader at Deloitte, comments, "The Centre is a significant investment by the firm and a key enabler of our strategy to develop the capabilities of the healthcare and life sciences practice in the UK and on the international stage.
"The Centre will cover a broad health and life sciences agenda, from pharmaceuticals and medical innovation, healthcare management and reform, to the patient and healthcare consumer. It will contribute to both a private and public sector perspective, placing Deloitte at the forefront of industry debate."
Rebecca George OBE, UK public sector health practice leader, adds, "At this time of great change and challenge for the NHS, the Centre will provide evidence-based analysis across organisational, regional and institutional boundaries. It will provide insight into the delivery of complex services in a fast changing environment which will help me and my teams deliver even more effective and targeted services."
The Centre, comprising a team of researchers, led by Karen Taylor, and assisted by Dr Karen Young, senior research manager, will work collaboratively with Deloitte's industry practitioners, and the firm's wider research teams.
Karen Taylor comments,"The environment in which healthcare and life sciences operate has never been more challenging, both financially and in terms of balancing the supply of and demand for services. With significant changes afoot in the healthcare sector, there will be numerous opportunities and challenges in the sector, particularly in light of the challenging financial climate.
"Against this background, I am delighted to have the opportunity to lead such an exciting and ambitious initiative, at a pivotal and challenging time in the development of new science and innovation within the healthcare and life sciences industry.
"I am a strong advocate of action based on evidence. The Centre, aims to identify solutions that involve new business models, new incentives, and accelerated use of new technology, such as information technologies, and which shift the focus of healthcare from providers to consumers. We will focus our research to provide a balanced, evidence-based view that will present insights, identify solutions and intelligence that influences policy makers, informs our clients and, importantly, benefits the end user, the patient."